| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |